Traders Buy C.R. Bard Inc. (BCR) on Weakness
Investors bought shares of C.R. Bard Inc. (NYSE:BCR) on weakness during trading on Friday. $17.41 million flowed into the stock on the tick-up and $10.62 million flowed out of the stock on the tick-down, for a money net flow of $6.79 million into the stock. Of all equities tracked, C.R. Bard had the 56th highest net in-flow for the day. C.R. Bard traded down ($0.29) for the day and closed at $221.21
A number of analysts have recently issued reports on the stock. Bank of America Corp. lowered shares of C.R. Bard from a “buy” rating to a “neutral” rating in a research report on Friday, July 8th. Jefferies Group increased their price target on shares of C.R. Bard from $215.00 to $237.00 and gave the stock a “hold” rating in a research report on Wednesday, July 27th. Barclays PLC increased their price target on shares of C.R. Bard from $212.00 to $224.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 24th. JPMorgan Chase & Co. increased their price target on shares of C.R. Bard from $214.00 to $225.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 27th. Finally, Leerink Swann reissued a “hold” rating on shares of C.R. Bard in a research report on Wednesday, May 25th. Thirteen investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $232.85.
The stock has a 50 day moving average of $223.14 and a 200 day moving average of $214.80. The company has a market cap of $16.25 billion and a price-to-earnings ratio of 51.44.
C.R. Bard (NYSE:BCR) last issued its quarterly earnings data on Tuesday, July 26th. The company reported $2.54 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.47 by $0.07. During the same quarter in the prior year, the firm posted $2.27 earnings per share. The business earned $931.50 million during the quarter, compared to analyst estimates of $915.22 million. C.R. Bard’s revenue for the quarter was up 8.3% compared to the same quarter last year. Analysts expect that C.R. Bard Inc. will post $10.17 EPS for the current year.
A hedge fund recently raised its stake in C.R. Bard stock. Schwab Charles Investment Management Inc. raised its stake in shares of C.R. Bard Inc. (NYSE:BCR) by 4.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 471,693 shares of the company’s stock after buying an additional 21,246 shares during the period. Schwab Charles Investment Management Inc. owned about 0.64% of C.R. Bard worth $89,358,000 as of its most recent filing with the SEC.
C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.